Michael Newman
Gründer bei INDAPTUS THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Michael Newman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INDAPTUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.08.2021 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.08.2021 | - | |
Gründer | 24.02.2021 | - |
Karriereverlauf von Michael Newman
Ehemalige bekannte Positionen von Michael Newman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Decoy Biosystems, Inc.
Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.08.2013 | 01.08.2021 |
Vorstandsvorsitzender | 01.08.2013 | 01.08.2021 | |
Finanzdirektor/CFO | 01.08.2013 | 01.08.2021 | |
Gründer | 01.08.2013 | 01.08.2021 | |
Präsident | 01.08.2013 | 01.08.2021 | |
Unternehmenssekretär | 01.08.2013 | 01.08.2021 | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.01.1992 | 01.01.1997 |
Brandeis University | Corporate Officer/Principal | 01.01.1984 | 01.01.1987 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 21.06.2021 | - |
Technik-/Wissenschafts-/F&E-Leiter | 21.06.2021 | - | |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Dihedron Corp. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ontogen Corp. | Corporate Officer/Principal | - | - |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Michael Newman
University of California San Diego | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Israel | 2 |
Operativ
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INDAPTUS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Vaxiion Therapeutics, Inc.
Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
Sandoz Pharmaceuticals Corp. | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Ontogen Corp. | |
Dihedron Corp. | |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Decoy Biosystems, Inc.
Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Michael Newman
- Erfahrung